Cargando…

Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma

OBJECTIVE: To investigate the risk factors of early postoperative recurrence in patients with single and small (≤3 cm) hepatitis B virus-associated primary hepatocellular carcinoma (HBV-HCC). METHODS: This retrospective study analyzed patients with single and small HBV-HCC. All patients were followe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Hongmei, Wang, Hui, Li, Guanghao, Hou, Qingshun, Wu, Wei, Liu, Fuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556173/ https://www.ncbi.nlm.nih.gov/pubmed/33044114 http://dx.doi.org/10.1177/0300060520961260

Ejemplares similares

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017)

Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
por: Hu, Xin-Sheng, et al.
Publicado: (2022)

Factors influencing early recurrence of hepatocellular carcinoma after curative resection
por: Zhu, Yu, et al.
Publicado: (2020)

Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2020)

Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease
por: Yang, Kwan Mo, et al.
Publicado: (2017)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma
por: Liu, Zhaobo, et al.
Publicado: (2020)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm)
por: Mei, Qi, et al.
Publicado: (2022)

Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience
por: Kim, Sang Jin, et al.
Publicado: (2021)

Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma
por: Khlaiphuengsin, Apichaya, et al.
Publicado: (2020)

Primary and secondary postoperative hemorrhage in pediatric tonsillectomy
por: Xu, Bin, et al.
Publicado: (2021)

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
por: Li, Shu-Qun, et al.
Publicado: (2023)

Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
por: Asahi, Yoh, et al.
Publicado: (2021)

Laparoscopic resection vs laparoscopic radiofrequency ablation for the treatment of small hepatocellular carcinomas: A single-center analysis
por: Casaccia, Marco, et al.
Publicado: (2017)

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma
por: Liu, Youde, et al.
Publicado: (2020)

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
por: Ye, Jia-Zhou, et al.
Publicado: (2017)

Development and validation of a postoperative pulmonary infection prediction model for patients with primary hepatic carcinoma
por: Lu, Chao, et al.
Publicado: (2023)

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
por: Murata, Ayato, et al.
Publicado: (2016)

Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma
por: Koga, Hiroki, et al.
Publicado: (2017)

Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor
por: Xu, Shuai-Shuai, et al.
Publicado: (2019)

Development of an innovative nomogram of risk factors to predict postoperative recurrence of gastrointestinal stromal tumors
por: Guan, Shi-Hao, et al.
Publicado: (2022)

Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation
por: Zhang, Qing, et al.
Publicado: (2016)

Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review
por: Xiong, Jian-Xia, et al.
Publicado: (2021)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China
por: Lei, Ming, et al.
Publicado: (2018)

Predictors of early postoperative hypocalcemia in patients with secondary hyperparathyroidism undergoing total parathyroidectomy
por: Gong, Wei, et al.
Publicado: (2021)

Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017)

Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
por: Huang, Bi-Xia, et al.
Publicado: (2020)

Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence
por: Purswani, Juhi M, et al.
Publicado: (2020)

Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
por: Tu, Hai-Bin, et al.
Publicado: (2021)

Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy
por: Chautant, Fiona, et al.
Publicado: (2020)

Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
por: Liu, Dong, et al.
Publicado: (2022)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation
por: Nguyen, Dung Thi, et al.
Publicado: (2023)

Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma
por: Kono, Hiroshi, et al.
Publicado: (2016)

Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma
por: Tarao, Kazuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04q2kvipj74b1jfmhnt5am554m